VIDEO: Racial disparities present in adjuvant therapy for pancreatic cancer
Click Here to Manage Email Alerts
In this video exclusive, Roi Anteby, MD, postdoctoral research fellow, department of surgery, Massachusetts General Hospital, discussed the affect of race, socioeconomic status and education on completion of adjuvant therapy for pancreatic cancer.
“Our next research focuses on the underlying reasons for disparities of care in the United States,” he said. “We assume and other data has shown they are multifactorial — have to do with access to care, difference in surgeon recommendations, lack of patient understanding or trust. We also have to acknowledge structural racism in the U.S. and that is in the form of racial segregation that we have shown in other types of cancer to be an underlying cause or the root of the problem of disparities in care. Hopefully by exposing them, we can address them.”
He said there were socioeconomic disparities in the use of adjuvant therapy in patients who underwent upfront surgical resection for pancreatic ductal adenocarcinoma.
Collapse
Anteby R, et al. Abstract 296. Presented at: Digestive Disease Week; May 21-24, 2021 (virtual meeting).
Read more about
Click Here to Manage Email Alerts